Работы, цитирующие эту работу

Работ: 2

Работа: Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer

1. Angiogenesis and prostate cancer: MicroRNAs comes into view

   Jitendra Gupta, Nahla A. Tayyib, Abduladheem Turki Jalil +7

   Обзорная статьяCircular RNAs in diseasesPathology - Research and Practice2023Цитирований: 2

   ABIABI:AkademIndex/openalex/2023.review-article.000048

2. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

   Vivek Panwar, Aishwarya Singh, Manini Bhatt +6

   Обзорная статьяPI3K/AKT/mTOR signaling in cancerSignal Transduction and Targeted Therapy2023Цитирований: 1

   ABIABI:AkademIndex/openalex/2023.review-article.000001